This response is provided to address the questions raised in the letter to the editor by Henni et al. on our manuscript (Kmiec et al. Magn Reson Med 2019;81:781-794) describing the development of a new method for transcutaneous oxygen measurement in humans based on electron paramagnetic resonance (EPR) technology using SPOT chip.